FDA To Decide If Three Genetic Parent Babies Method Gets A Pass
In the recent past, doctors have been able to perform tests on genes of animals and tried various reproductive techniques with human embryos. Over the years it really has begged the question as to whether invasive testing in pursuit of a healthy baby should be permitted. It seems like FDA (Food and Drug Administration) will have to weigh the pros and cons, and pass a conclusion on this soon. Whether fertility methods such as these can be allowed human clinical trials to produce babies with 3 genetic parents will soon be decided in the court of public opinion.
Oocyte modification is the term used for the 3-genetic parent baby producing technology. The process involves replacing a mutated mitochondrial DNA from an ill female’s egg with mutated mitochondrial of a healthy woman. Once the replacement takes place, the sperm is used to fertilize the egg in a lab upon which the embryo is placed back in the female. The offspring resulting from this exercise carries the best of all worlds (three in this case) as a consequence.
Since some inherited diseases can be transmitted through mutations, this method can prevent mitochondrial diseases that usually lead to other severities like seizures and poor eye sight. Although there no confirmation as to whether the quantity and quality of mitochondrial DNA could help battle fertility problems but it is a possibility. However, the approach isn’t without its downsides. For instance, it could lead with various other genetic traits like intelligence.
For now, the matter of three parent genetic babies is so full of controversy that it requires FDA’s green signal. Until we hear the final decision from the advisory committee on the subject, the fertility method will continue to be tested on animals only.